FDA Recalls, Market Withdrawals & Safety AlertsOther / 其他

Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)

Recall fda-alert:2024-12-20:Par Pharmaceutical:Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)Published 2024-12-20Company Endo, Inc.
Reason / 召回原因Product is an unapproved drug.
Distribution / 销售地区Not provided in the official record
Code information / 批次信息Not provided in the official record
i

Official-information notice / 官方信息说明
This page organizes fields from the named agency record. It is not medical, legal, or food-safety advice. Always compare your package with the official notice.

Official record details

官方记录详情:以原始机构公告为准

Recall number / 召回编号

fda-alert:2024-12-20:Par Pharmaceutical:Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)

Classification / 风险等级

Other / 其他

Published / 发布时间

2024-12-20

Recalling firm / 召回企业

Endo, Inc.

Product description / 产品描述

Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Not provided in the official record

Product quantity / 产品数量

Not provided in the official record

Distribution / 销售地区

Not provided in the official record

Reason for recall / 召回原因

Product is an unapproved drug.

Need the original notice?
Open the agency source for the complete official notice and any disposal, return, or contact instructions.

Open official source ↗

← Return to Recall Radar search / 返回搜索雷达

Last synchronized: 2024-12-20. Recall Radar does not replace agency guidance.